Your session is about to expire
← Back to Search
PrEP for HIV Prevention in Opioid Use Disorder (MOST Trial)
MOST Trial Summary
This trial will help PWID on MOUD improve their HIV prevention skills, motivation, and behaviors.
MOST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MOST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have proof of a PrEP prescription, confirming my HIV-negative status.I started PrEP within the last week.I am unable to give my consent.I am 18 years old or older.I am diagnosed with opioid dependence and follow a prescribed medication treatment.
- Group 1: Condition 1
- Group 2: Condition 2
- Group 3: Condition 3
- Group 4: Condition 4
- Group 5: Condition 5
- Group 6: Condition 6
- Group 7: Condition 7
- Group 8: Condition 8
- Group 9: Condition 9
- Group 10: Condition 10
- Group 11: Condition 11
- Group 12: Condition 12
- Group 13: Condition 13
- Group 14: Condition 14
- Group 15: Condition 15
- Group 16: Condition 16
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has Condition 2 been granted regulatory approval by the FDA?
"Due to the Phase 4 classification of Condition 2, our team have confidently assessed its safety with a score of 3."
Are there any remaining openings for test subjects in this research?
"Affirmative. According to details found on clinicaltrials.gov, this medical study has been recruiting since March 1st 2023 and the latest edit was made on March 22nd of the same year. 256 patients are required for participation at one specific location."
To what extent is the selection of participants for this trial being limited?
"Affirmative. The clinicaltrials.gov website confirms that this trial is currently recruiting patients, which began on March 1st 2023 and was last modified on March 22nd 2023. 256 individuals across a single site are required for the study to reach its enrollment goals."
Share this study with friends
Copy Link
Messenger